Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma

Kenji Yokoyama, Mitsuru Murata, Yasuo Ikeda, Shinichiro Okamoto

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The reported incidence of venous thromboembolism (VTE) in lymphoma patients is 5% to 17% in Western countries. The incidence and risk factors for developing VTE, however, are not well elucidated in Asian lymphoma patients. The incidence and clinical presentations of VTE were retrospectively assessed in 142 patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL) from April 2006 to November 2010 at Keio University Hospital. Clinical data were collected and all episodes of symptomatic VTE confirmed by imaging were included. Patients with primary central nervous system lymphoma or DLBCL transformed from prior low-grade lymphoma were excluded. Fifteen (11%) patients had at least one episode of VTE. Five patients developed VTE before beginning chemotherapy and 8 episodes of VTE occurred during the first three cycles of chemotherapy. By univariate analysis, age 60 or over (odds ratio [OR] 4.81, confidence interval [CI] 1.04-22.20, p = 0.04), Eastern Cooperative Oncology Group performance status 2, 3, or 4 (OR 39.90, CI 5.05-315.20, p = 0.0005), and International Prognostic Index high or high-intermediate (OR 9.40, CI 1.20-73.69, p = 0.03) were identified as risk factors for developing VTE. By multivariate analysis, performance status 2, 3, or 4 remained a significant risk factor for developing VTE (OR 31.14, CI 3.79-255.62, p = 0.001). The incidence of VTE in Japanese with DLBCL was comparable with that in the Western population. Patients with DLBCL and poor performance status at diagnosis were at high risk for developing VTE especially early in the course of treatment.

Original languageEnglish
Pages (from-to)7-11
Number of pages5
JournalThrombosis Research
Volume130
Issue number1
DOIs
Publication statusPublished - 2012 Jul

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Venous Thromboembolism
Incidence
Odds Ratio
Confidence Intervals
Lymphoma
Drug Therapy
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Multivariate Analysis
Central Nervous System

Keywords

  • Japanese
  • Lymphoma
  • Performance status
  • Venous thromboembolism

ASJC Scopus subject areas

  • Hematology

Cite this

Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma. / Yokoyama, Kenji; Murata, Mitsuru; Ikeda, Yasuo; Okamoto, Shinichiro.

In: Thrombosis Research, Vol. 130, No. 1, 07.2012, p. 7-11.

Research output: Contribution to journalArticle

@article{931359dcd6524d0d9b24c207364136be,
title = "Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma",
abstract = "The reported incidence of venous thromboembolism (VTE) in lymphoma patients is 5{\%} to 17{\%} in Western countries. The incidence and risk factors for developing VTE, however, are not well elucidated in Asian lymphoma patients. The incidence and clinical presentations of VTE were retrospectively assessed in 142 patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL) from April 2006 to November 2010 at Keio University Hospital. Clinical data were collected and all episodes of symptomatic VTE confirmed by imaging were included. Patients with primary central nervous system lymphoma or DLBCL transformed from prior low-grade lymphoma were excluded. Fifteen (11{\%}) patients had at least one episode of VTE. Five patients developed VTE before beginning chemotherapy and 8 episodes of VTE occurred during the first three cycles of chemotherapy. By univariate analysis, age 60 or over (odds ratio [OR] 4.81, confidence interval [CI] 1.04-22.20, p = 0.04), Eastern Cooperative Oncology Group performance status 2, 3, or 4 (OR 39.90, CI 5.05-315.20, p = 0.0005), and International Prognostic Index high or high-intermediate (OR 9.40, CI 1.20-73.69, p = 0.03) were identified as risk factors for developing VTE. By multivariate analysis, performance status 2, 3, or 4 remained a significant risk factor for developing VTE (OR 31.14, CI 3.79-255.62, p = 0.001). The incidence of VTE in Japanese with DLBCL was comparable with that in the Western population. Patients with DLBCL and poor performance status at diagnosis were at high risk for developing VTE especially early in the course of treatment.",
keywords = "Japanese, Lymphoma, Performance status, Venous thromboembolism",
author = "Kenji Yokoyama and Mitsuru Murata and Yasuo Ikeda and Shinichiro Okamoto",
year = "2012",
month = "7",
doi = "10.1016/j.thromres.2011.09.022",
language = "English",
volume = "130",
pages = "7--11",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma

AU - Yokoyama, Kenji

AU - Murata, Mitsuru

AU - Ikeda, Yasuo

AU - Okamoto, Shinichiro

PY - 2012/7

Y1 - 2012/7

N2 - The reported incidence of venous thromboembolism (VTE) in lymphoma patients is 5% to 17% in Western countries. The incidence and risk factors for developing VTE, however, are not well elucidated in Asian lymphoma patients. The incidence and clinical presentations of VTE were retrospectively assessed in 142 patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL) from April 2006 to November 2010 at Keio University Hospital. Clinical data were collected and all episodes of symptomatic VTE confirmed by imaging were included. Patients with primary central nervous system lymphoma or DLBCL transformed from prior low-grade lymphoma were excluded. Fifteen (11%) patients had at least one episode of VTE. Five patients developed VTE before beginning chemotherapy and 8 episodes of VTE occurred during the first three cycles of chemotherapy. By univariate analysis, age 60 or over (odds ratio [OR] 4.81, confidence interval [CI] 1.04-22.20, p = 0.04), Eastern Cooperative Oncology Group performance status 2, 3, or 4 (OR 39.90, CI 5.05-315.20, p = 0.0005), and International Prognostic Index high or high-intermediate (OR 9.40, CI 1.20-73.69, p = 0.03) were identified as risk factors for developing VTE. By multivariate analysis, performance status 2, 3, or 4 remained a significant risk factor for developing VTE (OR 31.14, CI 3.79-255.62, p = 0.001). The incidence of VTE in Japanese with DLBCL was comparable with that in the Western population. Patients with DLBCL and poor performance status at diagnosis were at high risk for developing VTE especially early in the course of treatment.

AB - The reported incidence of venous thromboembolism (VTE) in lymphoma patients is 5% to 17% in Western countries. The incidence and risk factors for developing VTE, however, are not well elucidated in Asian lymphoma patients. The incidence and clinical presentations of VTE were retrospectively assessed in 142 patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL) from April 2006 to November 2010 at Keio University Hospital. Clinical data were collected and all episodes of symptomatic VTE confirmed by imaging were included. Patients with primary central nervous system lymphoma or DLBCL transformed from prior low-grade lymphoma were excluded. Fifteen (11%) patients had at least one episode of VTE. Five patients developed VTE before beginning chemotherapy and 8 episodes of VTE occurred during the first three cycles of chemotherapy. By univariate analysis, age 60 or over (odds ratio [OR] 4.81, confidence interval [CI] 1.04-22.20, p = 0.04), Eastern Cooperative Oncology Group performance status 2, 3, or 4 (OR 39.90, CI 5.05-315.20, p = 0.0005), and International Prognostic Index high or high-intermediate (OR 9.40, CI 1.20-73.69, p = 0.03) were identified as risk factors for developing VTE. By multivariate analysis, performance status 2, 3, or 4 remained a significant risk factor for developing VTE (OR 31.14, CI 3.79-255.62, p = 0.001). The incidence of VTE in Japanese with DLBCL was comparable with that in the Western population. Patients with DLBCL and poor performance status at diagnosis were at high risk for developing VTE especially early in the course of treatment.

KW - Japanese

KW - Lymphoma

KW - Performance status

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=84861818300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861818300&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2011.09.022

DO - 10.1016/j.thromres.2011.09.022

M3 - Article

VL - 130

SP - 7

EP - 11

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 1

ER -